| 37.55 Real-Time Quote |  +0.065 / +0.17%Today’s Change | 28.45 Today|||52-Week Range 38.77 | +19.80% Year-to-Date |
| CE Mark for Abbott's Xience Xpedition 48 - Analyst Blog May 22 / Zacks.com | Analysts' Actions: ABT ACN GD KMX PCLN May 20 / TheStreet.com |
| 5 Drugs Stocks On The Rise May 20 / TheStreet.com |
| Previous close | 37.48 |
| Today’s open | 37.17 |
| Day’s range | 37.11 - 37.62 |
| Volume | 1,454,131 |
| Average volume (3 months) | 7,349,767 |
| Market cap | $58.4B |
| Dividend yield | 1.49% |
| Earnings growth (last year) | +24.45% |
| Earnings growth (this year) | -17.00% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | +2.63% |
| P/E ratio | 11.4 |
| Price/Sales | 2.59 |
| Price/Book | 2.21 |
| Today’s change | Today’s % change | |
|---|---|---|
| LLYEli Lilly and Co | -0.45 | -0.82% |
| AZNAstraZeneca PLC | -0.08 | -0.15% |
| CELGCelgene Corp | -1.49 | -1.21% |
| NVONovo Nordisk A/S | -0.88 | -0.52% |
| Next reporting date | July 17, 2013 |
| EPS forecast (this quarter) | $0.44 |
| Annual revenue (last year) | $39.9B |
| Annual profit (last year) | $6.0B |
| Net profit margin | 14.95% |
Sector Health Technology |
Industry Medical Specialties |
Chairman & Chief Executive Officer Miles D. White, MBA |
Chief Financial Officer & Executive Vice President Thomas C. Freyman, CPA |
Corporate headquarters Abbott Park, Illinois |
.
